REBECCA ZOBEL: Open Payments
NPI 1942827563 · CAYCE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$528 in 31 payments from 14 companies in 2025. Trend: 2023 $1,114 · 2024 $1,011 · 2025 $528
Food & beverage: $528
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 6 | $106 |
| ABBVIE INC. | 4 | $65 |
| SHIELD THERAPEUTICS INC | 3 | $54 |
| Novo Nordisk Inc | 3 | $49 |
| Novartis Pharmaceuticals Corporation | 2 | $39 |
| Amgen Inc. | 2 | $38 |
| GlaxoSmithKline, LLC. | 2 | $33 |
| AstraZeneca Pharmaceuticals LP | 2 | $31 |
| Daiichi Sankyo Inc. | 1 | $29 |
| Corcept Therapeutics | 1 | $20 |
Products named: NURTEC ODT, ACCRUFER, LEQVIO, SHINGRIX, AIRSUPRA, UBRELVY, Wegovy, INJECTAFER.
Industry payments across SC — which companies pay providers there.
